Expert consensus from the Arabian Gulf on selecting disease-modifying treatment for people with multiple sclerosis according to disease activity-Reference-Cited by-同舟云学术

Expert consensus from the Arabian Gulf on selecting disease-modifying treatment for people with multiple sclerosis according to disease activity

Published:2020-02-28 Issue:4 Volume:132 Page:368-376
ISSN:0032-5481
Container-title:Postgraduate Medicine
language:en
Short-container-title:Postgraduate Medicine

Author:

Alroughani Raed¹^ORCID,Inshasi Jihad²³,Al-Asmi Abdullah⁴,Alqallaf Abdulradha⁵,Al Salti Abdulla⁶,Shatila Ahmed⁷,Boshra Amir⁸,Canibano Beatriz⁹,Deleu Dirk⁹,Al Sharoqi Isa¹⁰¹¹,Al Khabouri Jaber¹²

Affiliation:

1. Department of Medicine, Amiri Hospital, Sharq, Kuwait

2. Department of Neurology, Rashid Hospital, Dubai, United Arab Emirates

3. Dubai Medical College, Dubai Health Authority (DHA), Dubai, United Arab Emirates

4. Neurology Unit, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman

5. Division of Neurology, Kuwait University Faculty of Medicine, Kuwait

6. Neuroscience Department, Khoula Hospital, Muscat, Oman

7. Neurology Department, Sheikh Shakhbout Medical City, Aby Dhabi, United Arab Emirates

8. Neurology and Immunology Medical Affairs - Patient Support Program, Gulf Region, Merck Serono Middle East FZ LTD, Dubai, United Arab Emirates

9. Department of Neurology (Neuroscience Institute), Hamad Medical Corporation, Doha, Qatar

10. Department of Neuroscience, Salmaniya Medical Complex, Manama, Bahrain

11. Neurology Department, Ministry of Health, Manama, Bahrain

12. Department of Neurology, The Royal Hospital, Muscat, Oman

Funder

Merck Serono Middle East FZ-ltd

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00325481.2020.1734394

Reference62 articles.

1. Multiple sclerosis is prominent in the Gulf states: Review

2. Multiple sclerosis in the Arabian Gulf countries: a consensus statement

3. Incidence and prevalence of multiple sclerosis in persian gulf area: A systematic review and meta-analysis

4. Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Practical Recommendations from the Gulf Region on the Therapeutic Use of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis: Impact of the Latest Real-World Evidence on Clinical Practice;Neurology and Therapy;2024-08-03

2. Practical Guidance on the Use of Cladribine Tablets in the Management or Relapsing Multiple Sclerosis: Expert Opinion from Qatar;Degenerative Neurological and Neuromuscular Disease;2023-12

3. Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study;Neurology and Therapy;2023-06-08

4. The Place of Immune Reconstitution Therapy in the Management of Relapsing Multiple Sclerosis in France: An Expert Consensus;Neurology and Therapy;2022-12-24

5. Real-world effectiveness and safety profile of teriflunomide in the management of multiple sclerosis in the Gulf Cooperation Council countries: An expert consensus narrative review;Multiple Sclerosis Journal - Experimental, Translational and Clinical;2022-01